Shandong Xinhua Pharmaceutical Co., Ltd

Hualu Network Group 中文版

Investor Relation

Information transparency and trust in peers

Investor Relation

INTERIM REPORT

Reply Slip for 2025 Annual General Meeting

Proxy Form for 2025 Annual General Meeting

Notice of The Annual General Meeting

Proposed Amendments To The Articles of Association And Notice of The Annual General Meeting

Overseas Regulatory Announcement-Announcement on Phenobarbital Tablets Having Passed the Generics Consistency Evaluation

Overseas Regulatory Announcement-Announcement on Ambroxol Hydrochloride and Clenbuterol Hydrochloride Oral Solution having obtained Drug Registration Certificate

Overseas Regulatory Announcement-Announcement on Benserazide Hydrochloride Having Obtained t

Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 April 2026

Reminder Letter and Reply Form to Non-registered Shareholders - Reminder Letter Regarding the Arrangement of Electronic Dissemination of Corporate Communications

Reminder Letter and Reply Form to Registered Shareholders - Reminder Letter Regarding the Arrangement of Electronic Dissemination of Corporate Communications

总条数: 79条

＜ 1 2 3 ... 8 ＞

跳转到: 页